  | Donis, N., Jiang, Z., D'Emal, C., Hulin, A., Debuisson, M., Dulgheru, R. E., Nguyen, M.-L., Postolache, A., LALLEMAND, F., COUCKE, P., Martinive, P., Herzog, M., Pamart, D., Terrell, J., Pincemail, J., Drion, P., DELVENNE, P., Nchimi Longang, A., LANCELLOTTI, P., & Oury, C. (28 February 2022). Differential Biological Effects of Dietary Lipids and Irradiation on the Aorta, Aortic Valve, and the Mitral Valve. Frontiers in Cardiovascular Medicine, 9, 1-16. doi:10.3389/fcvm.2022.839720  Peer Reviewed verified by ORBi |
 | Donis, N., Jiang, Z., D'Emal, C., DULGHERU, R. E., Giera, M., Blomberg, N., Delvenne, P., Nchimi Longang, A., Lancellotti, P., & Oury, C. (2021). Regular Dietary Intake of Palmitate Causes Vascular and Valvular Calcification in a Rabbit Model. Frontiers in Cardiovascular Medicine, 8, 692184. doi:10.3389/fcvm.2021.692184 Peer Reviewed verified by ORBi |
 | Oury, C., Donis, N., & Maréchal, P. (2020). Can Body Fat Cause Aortic Stenosis?: Lessons From Genetics. Journal of the American College of Cardiology, 75 (2), 177-179. doi:10.1016/j.jacc.2019.11.017 Peer Reviewed verified by ORBi |
 | Oury, C., MARECHAL, P., Donis, N., Hulin, A., Hego, A., TRIDETTI, J., Nguyen, M.-L., DULGHERU, R. E., Fillet, M., Nchimi Longang, A., & Lancellotti, P. (2020). Dexfenfluramine and Pergolide Cause Heart Valve Disease via Valve Metabolic Reprogramming and Ongoing Matrix Remodeling. International Journal of Molecular Sciences, 21 (11). doi:10.3390/ijms21114003 Peer Reviewed verified by ORBi |
 | MARTINEZ, C., Cicenia, M., SPRYNGER, M., Postolache, A., Ilardi, F., DULGHERU, R. E., Radermecker, M., Esposito, G., MARECHAL, P., Marechal, V., Donis, N., TRIDETTI, J., NGUYEN TRUNG, M.-L., Sugimoto, T., Tsugu, T., Go, Y. Y., Coisne, A., Montaigne, D., Fattouch, K., ... Lancellotti, P. (2020). Myocardial Function in Patients With Radiation-Associated Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Layer-Specific Strain Analysis Study. JACC. Cardiovascular Imaging. doi:10.1016/j.jcmg.2020.01.018 Peer Reviewed verified by ORBi |
 | LANCELLOTTI, P., MARECHAL, P., Donis, N., & Oury, C. (21 December 2019). Inflammation, cardiovascular disease, and cancer: a common link with far-reaching implications. European Heart Journal, 40 (48), 3910-3912. doi:10.1093/eurheartj/ehz645 Peer Reviewed verified by ORBi |
  | Donis, N., D'Emal, C., Hulin, A., Gustin, M., DULGHERU, R. E., LANCELLOTTI, P., & Oury, C. (22 November 2019). Platelets and aortic valve calcification: insights from a rabbit model and from patients with severe aortic stenosis [Paper presentation]. Belgian Working Group of Basic Research in Cardiology, Belgium. |
 | Donis, N., Oury, C., MOONEN, M., & Lancellotti, P. (2018). Treating cardiovascular complications of radiotherapy: a role for new pharmacotherapies. Expert Opinion on Pharmacotherapy, 19 (5), 431-442. doi:10.1080/14656566.2018.1446080 Peer Reviewed verified by ORBi |
 | Delierneux, C., Donis, N., Servais, L., Wéra, O., LECUT, C., Vandereyken, M., Musumeci, L., Rahmouni, S., Schneider, J., Eble, J., LANCELLOTTI, P., & Oury, C. (May 2017). Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides. Journal of Thrombosis and Haemostasis, 15 (5), 983-997. doi:10.1111/jth.13669 Peer Reviewed verified by ORBi |
 | Delierneux, C., Donis, N., Servais, L., Wéra, O., LANCELLOTTI, P., & Oury, C. (2017). Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: reply [letter to the editor]. Journal of Thrombosis and Haemostasis. doi:10.1111/jth.13876 Peer Reviewed verified by ORBi |